Cam Gallagher - 31 May 2024 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
/s/ Andrea Paul, attorney-in-fact for Cam S. Gallagher
Issuer symbol
ZNTL
Transactions as of
31 May 2024
Net transactions value
-$114,972
Form type
4
Filing time
31 May 2024, 18:27:15 UTC
Previous filing
12 Feb 2024
Next filing
13 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale $114,972 -9,597 -1.5% $11.98 633,680 31 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney